Literature DB >> 21051377

Leukocyte depletion during cardiopulmonary bypass in routine adult cardiac surgery.

J F Matthias Bechtel1, Simone Mühlenbein, Wolfgang Eichler, Michael Marx, Hans-Hinrich Sievers.   

Abstract

OBJECTIVES: Cardiopulmonary bypass (CPB) elicits an inflammatory response which is potentially harmful and that is partly caused by activation of leukocytes. Despite promise from earlier studies, however, the value of intraoperative leukocyte-depletion (LD) remains equivocal. We studied the effect of LD during routine cardiac surgery.
METHODS: For a short period (2.5 months), all operations at our institution were performed with leukocyte filters (Pall, East Hills, NY, USA) in the arterial and cardioplegia lines of the CPB. Those patients operated immediately before and after this period served as controls.
RESULTS: In each group, 266 predominantly male (70%) patients were studied. A broad spectrum of operations including emergency surgery was evaluated, which was comparable between the groups (P=0.41). There were no significant differences regarding the preoperative data, but the preoperative leukocyte count tended to be lower in the leukodepletion-group (7961±2415 vs. 8444±2951, P=0.050). Despite this, no difference between the groups regarding the postoperative leukocyte count was observed. Significantly more LD-patients were extubated within 12 h postoperatively (69% vs. 60% in the control-group, P=0.029), but there were no significant differences regarding 30-day mortality (0.4% vs. 1.1%, P=0.37), transfusion requirements or major morbidity.
CONCLUSIONS: In a retrospective study on adding LD filters to all cardiac operations with CPB in adults, we did not observe a clear benefit of intraoperative LD with the strategy used (continuous filtration plus filtration of cardioplegia).

Entities:  

Mesh:

Year:  2010        PMID: 21051377     DOI: 10.1510/icvts.2010.246868

Source DB:  PubMed          Journal:  Interact Cardiovasc Thorac Surg        ISSN: 1569-9285


  6 in total

1.  Clinical evaluation of leukocyte filtration as an alternative anti-inflammatory strategy to aprotinin in high-risk patients undergoing coronary revascularization.

Authors:  Bora Farsak; Serdar Gunaydin; Ulku Yildiz; Tamer Sari; Yaman Zorlutuna
Journal:  Surg Today       Date:  2011-11-10       Impact factor: 2.549

Review 2.  Leucoreduction of blood components: an effective way to increase blood safety?

Authors:  Maria Bianchi; Stefania Vaglio; Simonetta Pupella; Giuseppe Marano; Giuseppina Facco; Giancarlo M Liumbruno; Giuliano Grazzini
Journal:  Blood Transfus       Date:  2015-12-16       Impact factor: 3.443

Review 3.  [Perioperative inflammation].

Authors:  J Rossaint; A Margraf; A Zarbock
Journal:  Anaesthesist       Date:  2019-07       Impact factor: 1.041

Review 4.  Prevention of lung injury in cardiac surgery: a review.

Authors:  Robert W Young
Journal:  J Extra Corpor Technol       Date:  2014-06

Review 5.  Neuroprotective Strategies during Cardiac Surgery with Cardiopulmonary Bypass.

Authors:  Aida Salameh; Stefan Dhein; Ingo Dähnert; Norbert Klein
Journal:  Int J Mol Sci       Date:  2016-11-21       Impact factor: 5.923

6.  The effect of systemic arterial-line leukocyte filtration on the outcome of adult patients undergoing cardiac surgery.

Authors:  Hamidreza Taghipour; Hamid Shafiei; Omid Assar; Mohammad Saaid Ghiasi
Journal:  Iran Red Crescent Med J       Date:  2013-05-05       Impact factor: 0.611

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.